Incredible energy in the room today, thank you to everyone who came! 🙌

This Newcastle • Lyon • Paris collaboration will use CRISPR screening & single-cell sequencing in patient-derived models to find smarter drug combinations, with the aim of fast-tracking the most promising ones into early-phase trials.

Congratulations to both!

Their award-winning Microsatellite Instability Plus (MSI-Plus) assay combines the detection of MSI markers and BRAF/RAS mutations in one test — using advanced sequencing technology that works even from minimal DNA samples. 🧬

Read more here:

www.cancerresearchhorizons.com/news-and-eve...

👏 Congrats to Prof Robson & Dr Buskin (NU Cancer), Prof Heer (ICL) & Prof Chimusa (Northumbria) on securing £497K from @prostatecanceruk.bsky.social
to study gene mutations in men of African ancestry, helping to build new, representative disease models.

You can read the paper using the QR code below:

Eleanor’s work, part of the
@colospeed.bsky.social study
network, COLO-COHORT, aims to develop a tool to identify those most at risk of bowel cancer and polyps, and explore links between the microbiome and cancer development.

Great job Eleanor! 👏

Their important research aims to uncover possible causes behind the rise in early onset colorectal cancer (EOCRC) and improve early diagnosis and support services for those affected. 🧬💙

We're proud to see this vital work being recognised and funded! 🙌

Her clever Newcastle-themed example charmed the audience, helping to show why #LongReads > #ShortReads for this type of research.

Well done Eleanor! 🔬

The funding will help support his research efforts to understand how radiation can affect tumours, the immune system and liver tissue, and how radiation could make immunotherapies more effective.

Well done Abdullah!